Related references
Note: Only part of the references are listed.Function and clinical significance of N6-methyladenosine in digestive system tumours
Junchao Huang et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
Wei Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance
Qiang Wang et al.
GUT (2020)
Menadione reduces CDC25B expression and promotes tumor shrinkage in gastric cancer
Amanda Braga Bona et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)
m6A-binding proteins: the emerging crucial performers in epigenetics
Yanchun Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer
Qiang Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
RNA-binding proteins in tumor progression
Hai Qin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
被撤回的出版物: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis (vol 12, 135, 2019) (Retracted article. See vol. 16, 2023)
Dan Jin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
m6A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1
Huimin Guo et al.
FRONTIERS IN ONCOLOGY (2020)
CDC25B partners with PP2A to induce AMPK activation and tumor suppression in triple negative breast cancer
Junmei Cairns et al.
NAR CANCER (2020)
Reading, writing and erasing mRNA methylation
Sara Zaccara et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion
Tianfang Xia et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Reading, writing and erasing mRNA methylation
Sara Zaccara et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
MODOMICS: a database of RNA modification pathways. 2017 update
Pietro Boccaletto et al.
NUCLEIC ACIDS RESEARCH (2018)
HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g
Xiaoli Cai et al.
CANCER LETTERS (2018)
Role of N6-methyladenosine modification in cancer
Xiaolan Deng et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2
Mengnuo Chen et al.
HEPATOLOGY (2018)
FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting -catenin through mRNA demethylation
Shun Zhou et al.
MOLECULAR CARCINOGENESIS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition
Wenfeng Hua et al.
GYNECOLOGIC ONCOLOGY (2018)
m6A-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progression
Panpan Zhang et al.
CELL DEATH & DISEASE (2018)
Major Risk Factors in Head and Neck Cancer: A Retrospective Analysis of 12-Year Experiences
Anil Kumar Dhull et al.
WORLD JOURNAL OF ONCOLOGY (2018)
Post-transcriptional gene regulation by mRNA modifications
Boxuan Simen Zhao et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Apoptotic capacity and risk of squamous cell carcinoma of the head and neck
Zhensheng Liu et al.
EUROPEAN JOURNAL OF CANCER (2017)
Regulatory Role of N6-methyladenosine (m6A) Methylation in RNA Processing and Human Diseases
Wenqiang Wei et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
Isaia Barbieri et al.
NATURE (2017)
Epidemiology and Molecular Biology of Head and Neck Cancer
Adriana Jou et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA
Minjun Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Global DNA hypomethylation is associated with the development and poor prognosis of tongue squamous cell carcinoma
Hung-Chih Chen et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)
PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population
P. S. Sushma et al.
TUMOR BIOLOGY (2016)
Determination of DNA and RNA Methylation in Circulating Tumor Cells by Mass Spectrometry
Wei Huang et al.
ANALYTICAL CHEMISTRY (2016)
Global Epidemiology of Head and Neck Cancers: A Continuing Challenge
Bhawna Gupta et al.
ONCOLOGY (2016)
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA
Chuanzhao Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Messenger RNA modifications: Form, distribution, and function
Wendy V. Gilbert et al.
SCIENCE (2016)
N6-methyladenosine marks primary microRNAs for processing
Claudio R. Alarcon et al.
NATURE (2015)
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
Jonathan Ledermann et al.
LANCET ONCOLOGY (2014)
Gene expression regulation mediated through reversible m6A RNA methylation
Ye Fu et al.
NATURE REVIEWS GENETICS (2014)
Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker
Jinbang Li et al.
ONCOLOGY REPORTS (2014)
Aberrant promoter methylation of PTEN gene among Indian patients with oral squamous cell carcinoma
Nisreen S. Alyasiri et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2013)
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dan Dominissini et al.
NATURE (2012)
Differential expression of CDC25 phosphatases splice variants in human breast cancer cells
Helene Albert et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma
Jun Dong et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis
Dianne Pulte et al.
ONCOLOGIST (2010)
CDC25B: relationship with angiogenesis and prognosis in non-small cell lung carcinoma
Laura Boldrini et al.
HUMAN PATHOLOGY (2007)
CDC25 phosphatases in cancer cells: key players? Good targets?
Rose Boutros et al.
NATURE REVIEWS CANCER (2007)
Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression
Beatrix Bugler et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome
A Lindqvist et al.
JOURNAL OF CELL BIOLOGY (2005)
Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp.
SG Cao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma
JC Guo et al.
ONCOGENE (2004)
Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25
JS Lazo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma
S Hernández et al.
LABORATORY INVESTIGATION (2001)
Centrosomal and cytoplasmic cdc2/cyclin B1 activation precedes nuclear mitotic events
CPC De Souza et al.
EXPERIMENTAL CELL RESEARCH (2000)
Share Paper
